Heart Care Education Foundation is pleased to present:

CHANGING THE ODDS:

Dyslipidemia in the Metabolic Syndrome and Diabetes

Saturday Sept. 20, 2003   
Union League Club of Chicago 
                             ^{(click above to open a new browser for venue information)}
8:00am - 2:00pm
65 W. Jackson Blvd.
Main Dining Room,  6th Fl.
Chicago, IL   (312) 427-7800

Physicians...
Register now as seats are limited

Heart Care Education Foundation
of Illinois

FACULTY:

Inflammation, C-Reactive Protein and Cardiovascular Disease
Paul Ridker, MD, MPH
Director, Center for Cardiovascular Disease Prevention
Brigham and Women's Hospital
Professor, Dept. of Medicine
Division of Cardiology and Preventative Medicine
Harvard Medical School
Boston, Massachusetts

Diabetes & CHD
Steven Haffner, MD
Department of Medicine / Clinical Epidemiology
San Antonio, Texas

Metabolic Syndrome:  Controversies Regarding Diagnosis & Treatment
Neil J. Stone, MD
Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University Chicago, Illinois

High-Density Lipoproteins:  Epidemiology, Metabolism and Pharmacologic Management
Peter Toth, MD, PhD
Director of Cardiovascular Disease Prevention
Sterling Rock Falls Clinic
Sterling, Illinois

Strategies to Reduce the Burden of Obesity and Metabolic Syndrome
Robert O. Bonow, MD
Chief, Division of Cardiology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Lipoprotein Subclass: Abnormalities in the Metabolic Syndrome
Robert Rosenson, MD, FAHA
Director, Preventive Cardiology Center
Director, Lipoprotein and Hemorheology Research Facility
Assoc. Professor, Dept. of Medicine and Preventive Medicine
Feinberg School of Medicine
Northwestern University Chicago, Illinois

Efficacy and Safety of Combination Therapies
Michael Davidson, MD
Executive Medical Director, Radiant Research
Director, Preventive Cardiology Center
Assoc. Professor of Medicine
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois

OBJECTIVE:

This symposium will examine the relationship between metabolic syndrome, diabetes, dyslipidemia and the risk of coronary heart disease.  The targeted objective is to reduce cardiovascular risk in this patient population and to review the latest scientific information in dyslipidemia as it relates to metabolic syndrome and diabetes.

AGENDA:

the Metabolic Syndrome.  Paul Ridker, MD, MPH

Regarding Diagnosis & Treatment.  Neil J. Stone, MD

Epidemiology, Metabolism and Pharmacologic Management.   Peter Toth, MD, PhD

and Metabolic Syndrome.  Robert Bonow, MD

in the Metabolic Syndrome.  Robert Rosenson, MD

Michael Davidson, MD

2:00 pm           Concluding Remarks

Peter W. Kakavas,  M.D., F.A.C.C.
Director, Risk Factor Modification Program
Heart Care Centers of Illinois
Assistant Professor of Medicine
Rush-Presbyterian-St. Luke's Medical Center
Chicago, IL

PREMIER SPONSORS:

Bristol-Myers Squibb
Novartis Pharmaceuticals
Astra-Zeneca Pharmaceuticals
Schering-Plough Corporation

ADDITIONAL SUPPORT PROVIDED BY:

Abbott Laboratories
Kos Pharmaceuticals

TARGET AUDIENCE:

The target audience for this activity is cardiologists, internists, endocrinologists, and family practitioners with an interest in the management of patients with dyslipidemia, diabetes, and the metabolic syndrome.

      ACCREDITATION: 

The Heart Care Education Foundation is accredited by the Illinois State Medical Society to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the policies of the Illinois State Medical Society through the sponsorship of the Heart Care Education Foundation.

The Heart Care Education Foundation designates this educational activity for a maximum of 3.5 credits in Category I toward the AMA Physicians' Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

ACTIVITY FEE:

There is no fee to attend this CME event.

For more information or to register call Phyllis Gedzun at (708) 478-3600
Please RSVP without delay as seats are limited.